Literature DB >> 29149768

Mitochondrial DNA changes in pedunculopontine cholinergic neurons in Parkinson disease.

Alexander G Bury1, Angela Pyle2, Joanna L Elson1,3, Laura Greaves2, Christopher M Morris4, Gavin Hudson2, Ilse S Pienaar5,6.   

Abstract

In Parkinson disease (PD), mitochondrial dysfunction associates with nigral dopaminergic neuronal loss. Cholinergic neuronal loss co-occurs, particularly within a brainstem structure, the pedunculopontine nucleus (PPN). We isolated single cholinergic neurons from postmortem PPNs of aged controls and PD patients. Mitochondrial DNA (mtDNA) copy number and mtDNA deletions were increased significantly in PD patients compared to controls. Furthermore, compared to controls the PD patients had significantly more PPN cholinergic neurons containing mtDNA deletion levels exceeding 60%, a level associated with deleterious effects on oxidative phosphorylation. The current results differ from studies reporting mtDNA depletion in nigral dopaminergic neurons of PD patients. Ann Neurol 2017;82:1016-1021.
© 2017 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29149768     DOI: 10.1002/ana.25099

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  19 in total

Review 1.  The unresolved role of mitochondrial DNA in Parkinson's disease: An overview of published studies, their limitations, and future prospects.

Authors:  Amica C Müller-Nedebock; Rebecca R Brennan; Marianne Venter; Ilse S Pienaar; Francois H van der Westhuizen; Joanna L Elson; Owen A Ross; Soraya Bardien
Journal:  Neurochem Int       Date:  2019-06-21       Impact factor: 3.921

2.  Single-Cell Approaches for Studying the Role of Mitochondrial DNA in Neurodegenerative Disease.

Authors:  Laura J Bailey; Joanna L Elson; Ilse S Pienaar
Journal:  Methods Mol Biol       Date:  2021

3.  Acanthopanax senticosus Protects Structure and Function of Mesencephalic Mitochondria in A Mouse Model of Parkinson's Disease.

Authors:  Shu-Min Liu; Xu-Zhao Li; Shuai-Nan Zhang; Zhi-Ming Yang; Ke-Xin Wang; Fang Lu; Chong-Zhi Wang; Chun-Su Yuan
Journal:  Chin J Integr Med       Date:  2018-08-08       Impact factor: 1.978

4.  Targeted activation of midbrain neurons restores locomotor function in mouse models of parkinsonism.

Authors:  Débora Masini; Ole Kiehn
Journal:  Nat Commun       Date:  2022-01-26       Impact factor: 14.919

Review 5.  Dopaminergic Axons: Key Recitalists in Parkinson's Disease.

Authors:  Abhishek Kumar Mishra; Anubhuti Dixit
Journal:  Neurochem Res       Date:  2021-10-12       Impact factor: 3.996

6.  Stress and Psychiatric Disorders: The Role of Mitochondria.

Authors:  Teresa E Daniels; Elizabeth M Olsen; Audrey R Tyrka
Journal:  Annu Rev Clin Psychol       Date:  2020-02-24       Impact factor: 18.561

7.  Cortisol levels, motor, cognitive and behavioral symptoms in Parkinson's disease: a systematic review.

Authors:  Nayron Medeiros Soares; Gabriela Magalhães Pereira; Vivian Altmann; Rosa Maria Martins de Almeida; Carlos R M Rieder
Journal:  J Neural Transm (Vienna)       Date:  2018-10-29       Impact factor: 3.575

8.  Mitochondria and early-life adversity.

Authors:  Emily K Zitkovsky; Teresa E Daniels; Audrey R Tyrka
Journal:  Mitochondrion       Date:  2021-01-21       Impact factor: 4.160

9.  MtDNA population variation in Myalgic encephalomyelitis/Chronic fatigue syndrome in two populations: a study of mildly deleterious variants.

Authors:  Marianne Venter; Cara Tomas; Ilse S Pienaar; Victoria Strassheim; Elardus Erasmus; Wan-Fai Ng; Neil Howell; Julia L Newton; Francois H Van der Westhuizen; Joanna L Elson
Journal:  Sci Rep       Date:  2019-02-27       Impact factor: 4.379

10.  Mitochondrial D-Loop Region Methylation and Copy Number in Peripheral Blood DNA of Parkinson's Disease Patients.

Authors:  Andrea Stoccoro; Adam R Smith; Filippo Baldacci; Claudia Del Gamba; Annalisa Lo Gerfo; Roberto Ceravolo; Katie Lunnon; Lucia Migliore; Fabio Coppedè
Journal:  Genes (Basel)       Date:  2021-05-12       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.